South and Central America Next-generation Antibody Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Next-generation Antibody Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Next-generation Antibody Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Next-generation Antibody Market Regional Analysis

6.2 South and Central America Next-generation Antibody Market Revenue 2019-2028 (US$ Million)

6.3 South and Central America Next-generation Antibody Market Forecast Analysis

7. South and Central America Next-generation Antibody Market Analysis – by Therapeutic Area

7.1 Oncology

7.1.1 Overview
7.1.2 Oncology: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Autoimmune or Inflammatory

7.2.1 Overview
7.2.2 Autoimmune or Inflammatory: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South and Central America Next-generation Antibody Market Analysis – by Technology

8.1 Antibody-drug conjugates

8.1.1 Overview
8.1.2 Antibody-drug conjugates: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Bispecific antibodies

8.2.1 Overview
8.2.2 Bispecific antibodies: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Fc engineered antibodies

8.3.1 Overview
8.3.2 Fc engineered antibodies: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Antibody fragments & antibody-like proteins

8.4.1 Overview
8.4.2 Antibody fragments & antibody-like proteins: South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Biosimilar antibody products

8.5.1 Overview
8.5.2 Biosimilar antibody products : South and Central America Next-generation Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South and Central America Next-generation Antibody Market – South and Central America Analysis

9.1 Overview

9.2 South and Central America

9.2.1 South and Central America Next-generation Antibody Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 South and Central America Next-generation Antibody Market – Revenue and Forecast Analysis – by Country
9.2.1.1 Brazil: South and Central America Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 Brazil: South and Central America Next-generation Antibody Market Breakdown, by Therapeutic Area
9.2.1.1.2 Brazil: South and Central America Next-generation Antibody Market Breakdown, by Technology

9.2.1.2 Argentina: South and Central America Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Argentina: South and Central America Next-generation Antibody Market Breakdown, by Therapeutic Area
9.2.1.2.2 Argentina: South and Central America Next-generation Antibody Market Breakdown, by Technology

9.2.1.3 Rest of South and Central America : South and Central America Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Rest of South and Central America : South and Central America Next-generation Antibody Market Breakdown, by Therapeutic Area
9.2.1.3.2 Rest of South and Central America : South and Central America Next-generation Antibody Market Breakdown, by Technology

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 F. HOFFMANN-LA ROCHE LTD.

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Takeda Pharmaceutical Company Limited

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Pfizer Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Catalent Inc

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 AstraZeneca

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

South and Central America Next-generation Antibody Market

Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)